Clinical Trials Logo

Filter by:
NCT ID: NCT05823584 Completed - Clinical trials for Hepatocellular Carcinoma

Cell-free DNA From Junction of Hepatitis B Virus Integration in HCC Patients for Monitoring Post-resection Recurrence

Start date: December 22, 2019
Phase:
Study type: Observational

HBV DNA integration has been found in the chromosomes of about 90% of HBV-related HCC and the integration site is unique to individual HCC. The virus-host chimera DNA (vh-DNA) from HBV integration sites in HCC a reliable evidence even in the patient with a tiny tumor which is not large enough to be detected by the image scan. The goal of this observational study is to compare the prediction ability of vh-DNA with the other biomarkers for monitoring the recurrent of HBV-related HCC. The main questions that aim to answer are the sensitivity and specificity of vh-DNA/AFP/ALP-L3/PIVKA-II/TERTC2280 when the gold standard is the guideline of HCC diagnosis. The surgical tissues and plasma samples from the participants would be collected undergoing the HCC recession surgery when joining the study at the beginning, in order to identify the HBV integration in tumor by Capture NGS and quantify the specific vh-DNA in plasma by ddPCR as personalized biomarkers for minimal residual disease (MRD) monitoring. Moreover, the consistency of vh-DNA from tumor will be validated by pre-operative plasma. Then the participants will be asked to performed the visit at 2, 5, 8, 11, 14 months after the HCC recession surgery. The plasma sample for vh-DNA/AFP/ AFP-L3/ PIVKA-II/ TERTp C228T testing and the image data from ultrasound, CT or MRI would also be collected at these visits. When the vh-DNA testing result is positive and there is no recurrence at 14 months after the HCC recession surgery, some participants will be asked to followed at 17, 20 months. Researcher will compare the sensitivity, specificity and predict day of vh-DNA with AFP/ AFP-L3/ PIVKA-II/ TERTp C228T as a biomarker for HCC surveillance. The true value of this novel HBV chimera vh-DNA will be revealed. The results will also support to use for monitoring post-operative recurrence. In addition, the investigators will explore the performance of TERTp C228T mutation from non-HBV HCC patients. As a different target of ctDNA for HCC, TERTp C228T will be identified using surgical tissues from HCC patients, and plasma samples from the same patient before/after operation will be tested by ddPCR . It will be evaluated that TERTp C228T is predictive or not for recurrence monitoring of HCC.

NCT ID: NCT05822960 Completed - Clinical trials for Peripheral Arterial Disease

To Investigate the Effect of Far-infrared Radiation on Lower Extremity Acupoints on the Blood Circulation of Lower Extremities in Patients With Hemodialysis

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

This study intends to irradiate the acupoints of both lower extremities of hemodialysis patients with far-infrared therapeutic apparatus to explore its effect on foot blood circulation, peripheral artery occlusion disease (PAOD) symptoms and ankle-brachial index (Ankle-Brachial Index, ABI) value.

NCT ID: NCT05817708 Completed - COVID-19 Clinical Trials

A Study of Silmitasertib (CX-4945) in Healthy Subject

Start date: November 7, 2022
Phase: Phase 1
Study type: Interventional

This is a Phase I single center, open-label, parallel design in 30 subjects to evaluate safety and tolerability of CX-4945 200mg QD, 200 mg BID and 400mg BID doses (10 subjects in each regimen) for continuously 5 days in healthy subjects for dose selection.

NCT ID: NCT05814120 Completed - Community Dwelling Clinical Trials

Effectiveness of Basic Life Support Training for Rural Community Dwelling Elderly

Start date: May 1, 2021
Phase: N/A
Study type: Interventional

The goal of this pre-post study is to test the effectiveness of basic life support (BLS) training for rural community-dwelling Elderly. The main question it aims to answer are can the training program tailored for rural elderly improve basic life support knowledge, attitude, and skills? Participants will receive an innovative BLS training program.

NCT ID: NCT05810909 Completed - Osteopenia Clinical Trials

Effects of Amorphous Calcium Carbonate Supplementation on Bone Health in Postmenopausal Women With Osteopenia

Start date: December 10, 2019
Phase: N/A
Study type: Interventional

This research was designed in accordance to the Method for Efficacy Assessment of Health Food for Bone Heath. Changes to bone density were measured to evaluate the effectiveness of amorphous calcium carbonate in maintaining bone health.

NCT ID: NCT05810090 Completed - Clinical trials for Satisfaction, Patient

The Outcomes of Subject After Total Knee Arthroplasty

Start date: January 12, 2017
Phase:
Study type: Observational

Total Knee Arthroplasty (TKA) is a standard of intervention for severe knee osteoarthritis, also been proven with benefits in improving pain, mobility, and quality of life. However, the outcomes after TKA is controversial.

NCT ID: NCT05809765 Completed - Clinical trials for Hemodialysis Complication

Effect of Triflow Breathing Training

Start date: May 16, 2020
Phase: N/A
Study type: Interventional

This study aims to explore whether an 8-week Triflow breath training program reduced the anxiety levels and improved the heart rate variability and quality of life of patients receiving hemodialysis. To investigate the effect of the triflow respiration training on the improvement of heart rate variability, anxiety, and the quality of life in hemodialysis patients.

NCT ID: NCT05808777 Completed - Clinical trials for Intra Cerebral Hemorrhage

Validation of the ICH Score for the Prediction of 12-month Functional Outcome in Patients With Primary Intracerebral Hemorrhage

Start date: June 24, 2019
Phase:
Study type: Observational

The goal of this observational study is to analyze the validity of the intracerebral hemorrhage (ICH) Score and a new modified ICH score for the prediction of 12-month functional outcome in patients with primary ICH. Participants who were admitted to NTUH rehabilitation ward will be followed up to 12 months after the onset of ICH. The follow-up will be conducted by phone interviews.

NCT ID: NCT05808491 Completed - Clinical trials for Health Promotion Program

Online Resilience Intervention in Older Adults

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

Resilience in older adults is important for Healthy aging. The purpose of this study was to examine the effectiveness of an on-line program of resilience interventions among older adults.

NCT ID: NCT05808426 Completed - Aged Clinical Trials

Benefits of Online Mahjong by Older Adults

Start date: July 28, 2020
Phase: N/A
Study type: Interventional

This study aims to examine the clinical efficacy of online Mahjong in improving physical health, cognitive performance, happiness, laboratory biomarkers, and structural brain imaging (magnetic resonance imaging, MRI) by a randomized controlled trial design, and hopefully to expand the scope of healthy aging intervention activities with strong scientific evidence.